RMD logo

ResMed Inc. (RMD)$208.05

Market Cap: 35.29 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for ResMed Inc. (RMD).

HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
DCF ready

Valuation

20.9x

EV/FCF, 4.8% FCF yield

Quality

21.1%

ROIC, 32.3% FCF margin

Growth

11.7%

5Y sales (revenue) CAGR

Balance sheet

0.1x

Debt/equity, 3.4x current ratio

Superinvestors

1

Top: Francois Rochon (1.9%)

Strengths to research

  • Revenue compounded at 11.7% over five years.
  • Free cash flow compounded at 18.6% over five years.
  • Return on equity is strong at 23.5%.
  • Free cash flow margin is healthy at 32.3%.

Watchouts

No major valuation, balance sheet, or growth watchouts were detected by the static screen.

Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for RMD.

Grade C
65
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
RMD
Target
ResMed Inc.$35.3B21.9x20.9x21.1%11.7%32.3%59.4%-0.3xN/A
BDXBecton Dickinson$47.9B25.4x17.7x6.6%6.3%12.2%N/A-0.1xN/A
ALCAlcon Inc.$48.2B9.3x22.1x30.5%N/A28.8%76.7%-0.9xN/A
COOCooper Cos Inc$16.3B33.4x37.4x4.6%11.0%10.6%65.5%-0.1xN/A
BAXBaxter International Inc.$15.6B-10.3x69.5x-6.1%-0.7%3.0%30.1%11.1xN/A
ALGNAlign Technology Inc.$13.0B29.0x24.3x10.1%10.3%12.2%67.2%-1.4xN/A
HOLXHologic Inc.$11.8BN/AN/AN/AN/AN/AN/AN/AN/A
SOLVSolventum Corp$11.6B8.7x-1572.9x15.4%N/A-0.1%53.5%1.6xN/A
AVTRAvantor arinc.$8.6B-10.4x24.6x-5.6%0.5%7.6%32.7%N/AN/A

Financial Charts

No financial data available for RMD (annual).

1 superinvestors own RMD

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Francois Rochon

Giverny Capital

230,005$52M1.89%0.0%